{"schema_version":"secwatch.filing_event.v1","accession":"0001159036-25-000022","form_type":"8-K","ticker":"HALO","cik":"0001159036","company_name":"HALOZYME THERAPEUTICS, INC.","filed_at":"2025-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.664533+00:00","generated_at":"2026-05-22T22:06:32.453140+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Halozyme stockholders elect two Class III directors and approve say-on-pay at annual meeting","bullets":["Jeffrey W. Henderson elected with 98,993,463 votes for, 3,298,117 against; Helen I. Torley elected with 101,477,199 for, 816,675 against.","Say-on-pay proposal approved: 98,252,464 for, 3,966,034 against, 168,127 abstain.","Ratification of Ernst & Young as 2025 auditor approved: 112,028,211 for, 659,976 against, 78,816 abstain.","Meeting held May 1, 2025; 112,767,003 shares represented out of 123,533,310 outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001159036-25-000022","json":"https://secwatch.observer/filing/0001159036-25-000022.json","markdown":"https://secwatch.observer/filing/0001159036-25-000022.md","text":"https://secwatch.observer/filing/0001159036-25-000022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1159036/000115903625000022/0001159036-25-000022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1159036/000115903625000022/halo-20250501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T22:06:32.453140+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}